Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Arthritis, Psoriatic × tofacitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Psoriasis 7 Lymphoma, Follicular 7 Bronchiolitis Obliterans Syndrome 7 Pruritus 5 Arthritis, Rheumatoid 3 Plaque, Amyloid 1 Arthritis, Psoriatic 1

Interventions

guselkumab 2 tofacitinib 1 sonelokimab 1 risankizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01519089 2015-08-13

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Pfizer

Phase 3 Completed

95 enrolled 37 charts

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡